The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global liver disease treatment market was valued at US$ 20.83 Billion in 2021.
We expect the global liver disease treatment market to exhibit a CAGR of 6.50% during 2022-2027.
The rising geriatric population, along with the increasing prevalence of fatty liver disease, owing to the
high cholesterol level, obesity, hypertension, etc., is primarily driving the global liver disease treatment
The sudden outbreak of the COVID-19 pandemic had led to postponement of numerous elective
treatment procedures to reduce the risk of coronavirus infection upon hospital visits or interaction with
healthcare professionals and medical equipment.
Based on the treatment type, the global liver disease treatment market can be segmented into antiviral
drugs, immunosuppressants, vaccines, immunoglobulins, corticosteroids, targeted therapy, and
chemotherapy. Currently, antiviral drugs hold the majority of the total market share.
Based on the disease type, the global liver disease treatment market has been divided into hepatitis,
autoimmune diseases, Non-alcoholic Fatty Liver Disease (NAFLD), cancer, genetic disorders, and others.
Among these, hepatitis exhibits a clear dominance in the market.
Based on the end user, the global liver disease treatment market can be categorized into hospitals,
ambulatory surgical centers, and others. Currently, hospitals account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global liver disease treatment market include Abbott Laboratories,
AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent
BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc.,
Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and Viatris Inc.
Home Healthcare Market by Product (Therapeutic Products, Testing, Screening, and Monitoring Products, Mobility Care Products), Service (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care), Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at